French reimbursement decisions:
This article was originally published in Clinica
The French health ministry published a series of decrees on December 1 granting reimbursement to the following companies for their medical devices: Smith & Nephew, for its zirconium oxide hip implant; Biotech International, for its Meniscus Arrow miniscal implant; and Labcor Laboratories for its heart valve, Labcor Synergie TM ST-Porcin. A further decree, published on December 2, grants reimbursement status to St Jude Medical for a range of Identity ADX dual chamber pacemakers. The decrees set out the reimbursement rates for these products.
You may also be interested in...
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.
Dozens of life science companies are working to find effective treatments for COVID-19. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into some of the efforts that are under way on this front.
Market researcher The NPD Group identifies the few prestige beauty categories that posted sales growth in the US for the week ending 28 March. Companies that can pivot or ramp up activities in winning segments – and reach consumers digitally while they shelter at home – may fare best during the coronavirus pandemic.